Meningitis vaccine
US4307080A · kind A · utility
1Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 1980 |
| Grant date | Dec 22, 1981 |
| Priority date | — |
| Expiry date | Sep 22, 2000 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/102
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A high molecular weight capsular polysaccharide from H. influenza type b is an effective immunogenic agent against infection caused by the H. influenza type b bacterium.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.